Gentherm (THRM) Earnings Date & Reports

Key Takeaways

• Product revenue reached $405.1 million, up 4.7% year over year, narrowly topping consensus estimates of roughly $404 million.
• Adjusted diluted earnings per share (EPS) came in at $0.33, well below the consensus of about $0.65, driven by higher tax rates tied to deal costs.
• Gross margin slipped to 23.3% from 24.6% a year earlier on foreign exchange, material costs, and inflation.
• The company completed its combination with Modine Performance Technologies on October 1 and raised full-year 2026 revenue and adjusted EBITDA guidance.
• Gentherm repurchased $60 million of stock in October, with about $340 million remaining under its buyback authorization.

Earnings Context and Why It Matters

Gentherm (THRM), a maker of thermal and precision flow management technologies, delivered third-quarter results that highlight both steady commercial momentum and meaningful margin pressure. The report is especially important because it is the first since the company closed its transformative combination with Modine Performance Technologies, expanding its reach beyond automotive seats into power generation, commercial vehicles, and heavy-duty equipment. Investors are watching closely to see whether the core automotive business can keep growing above market while management absorbs transaction costs, inflation, and currency headwinds. With new business awards remaining strong and full-year guidance moving higher, the quarter underscores a company in transition rather than one standing still.

Reported Results

For the third quarter ended September 30, 2026, Gentherm reported product revenue of $405.1 million, a 4.7% increase from $386.9 million a year earlier and a 4.4% gain excluding the impact of foreign currency translation (ex-FX). Revenue slightly exceeded analyst estimates of about $404 million. Automotive Climate and Comfort Solutions revenue rose 8.8% to $346.4 million, outperforming light vehicle production in relevant markets by 12 percentage points, while the Medical segment grew 14.6% to $14.5 million.

Profitability was the weak spot. Adjusted diluted EPS was $0.33, missing the consensus of roughly $0.65 by $0.32 and down from $0.73 in the prior-year quarter. On a GAAP (generally accepted accounting principles) basis, the company recorded a net loss of $2.6 million, or $0.08 per diluted share, compared with net income of $14.9 million, or $0.49 per share, a year ago. The decline reflected merger and restructuring expenses of about $0.37 per share and a higher tax rate tied to the timing of M&A (mergers and acquisitions) costs.

Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) totaled $45.0 million, or 11.1% of revenue, down from $49.0 million, or 12.7%, in the prior-year period. Gross margin declined to 23.3% from 24.6%, pressured by foreign exchange, higher net material costs, and inflation. Operating cash flow fell to $36.0 million from $87.8 million, while adjusted free cash flow was $59.5 million versus $72.3 million a year ago.

Management raised full-year 2026 guidance to reflect the Modine contribution: product revenue of $1.825 billion to $1.925 billion, adjusted EBITDA of $210 million to $230 million, and adjusted free cash flow of $100 million to $120 million.

AI Screener

For investors looking to identify opportunities across the market more efficiently, Tickeron's AI Screener is an AI-powered stock and ETF (exchange-traded fund) discovery tool. It helps traders and investors filter thousands of stocks and ETFs using customizable criteria such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending stocks, breakout candidates, and market opportunities by applying technical, fundamental, and AI-driven signals, reducing the time spent on manual screening. Whether you are tracking earnings movers like Gentherm or scanning for emerging trends, the AI Screener can help you stay ahead of the market.

Market Reaction and Investor Sentiment

Shares of Gentherm fell sharply following the release, tumbling about 7% in early trading, as investors focused on the earnings miss rather than the revenue beat. The stock had already been under pressure, trading down more than 20% over the prior twelve months, and the report pushed it toward the lower end of its recent range. The reaction suggests the market was caught off guard by the magnitude of the adjusted EPS shortfall and the compression in margins, even as management described results as "in line with expectations." The strong automotive award momentum and raised guidance provided a counterweight, but near-term sentiment remains cautious amid persistent cost inflation and integration execution risk.

Forward Outlook and Key Factors to Monitor

Following this report, the investment narrative shifts toward the integration of Modine Performance Technologies and the company's ability to convert its larger scale into higher margins. Management pointed to a path toward more than $3.5 billion in revenue and over $500 million in adjusted EBITDA by 2030, along with a $25 million cost synergy target from the combination.

Several factors warrant attention in the coming quarters. First, watch whether freight and material cost inflation eases, since these were the primary drivers of the margin decline. Second, monitor the pace of customer cost-recovery negotiations, which management indicated could take time. Third, track the integration of Modine's power generation, commercial vehicle, and heavy-duty equipment businesses, including the expected fourth-quarter contribution.

On the demand side, the company secured $555 million in automotive new business awards during the quarter, bringing the year-to-date total above $1.6 billion and keeping it on track for a fourth straight year of at least $2 billion. New market initiatives, including the ThermAffyx patient safety system, the home and office expansion, and an initial air-moving device award in India, offer additional growth avenues. Finally, capital allocation remains a factor, with Gentherm signaling it will stay active on share repurchases in the fourth quarter given its view that the stock is undervalued.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations